Fluorescence PCR

Multiplex real-time PCR | Melting curve technology | Accurate | UNG System | Liquid & lyophilized reagent

Fluorescence PCR

  • Poliovirus Type Ⅲ

    Poliovirus Type Ⅲ

    This kit is suitable for the qualitative detection of Poliovirus Type Ⅲ nucleic acid in human stool samples in vitro.

  • Poliovirus Type Ⅰ

    Poliovirus Type Ⅰ

    This kit is suitable for the qualitative detection of poliovirus type I nucleic acid in human stool samples in vitro.

  • Poliovirus Type Ⅱ

    Poliovirus Type Ⅱ

    This kit is suitable for the qualitative detection of Poliovirus Type Ⅱnucleic acid in human stool samples in vitro.

  • Enterovirus 71 (EV71)

    Enterovirus 71 (EV71)

    This kit is intended for the in vitro qualitative detection of enterovirus 71 (EV71) nucleic acid in oropharyngeal swabs and herpes fluid samples of patients with hand-foot-mouth disease.

  • Enterovirus Universal

    Enterovirus Universal

    This product is intended for the in vitro qualitative detection of enteroviruses in oropharyngeal swabs and herpes fluid samples. This kit is for aid to diagnosis of hand-foot-mouth disease.

  • Herpes Simplex Virus Type 1

    Herpes Simplex Virus Type 1

    This kit is used for the qualitative detection of Herpes Simplex Virus Type 1 (HSV1).

  • Chlamydia Trachomatis, Neisseria Gonorrhoeae and Trichomonas vaginalis

    Chlamydia Trachomatis, Neisseria Gonorrhoeae and Trichomonas vaginalis

    The kit is intended for the in vitro qualitative detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonal vaginitis (TV) in male urethral swab, female cervical swab, and female vaginal swab samples, and provide aid to the diagnosis and treatment of patients with genitourinary tract infections.

  • Trichomonas Vaginalis Nucleic Acid

    Trichomonas Vaginalis Nucleic Acid

    This kit is used for the qualitative detection of Trichomonas vaginalis nucleic acid in human urogenital tract secretion samples.

  • Respiratory Pathogens Combined

    Respiratory Pathogens Combined

    This kit is used for qualitative detection of respiratory pathogens in nucleic acid extracted from human oropharyngeal swab samples.

    This model is used for the qualitative detection of 2019-nCoV, influenza A virus, influenza B virus and respiratory syncytial virus nucleic acids in human oropharyngeal swab samples.

  • Respiratory Pathogens Combined

    Respiratory Pathogens Combined

    This kit is used for the in vitro qualitative detection of influenza A virus, influenza B virus, respiratory syncytial virus, adenovirus, human rhinovirus and mycoplasma pneumoniae nucleic acids in human nasopharyngeal swabs and oropharyngeal swab samples. The test results can be used for aid to the diagnosis of respiratory pathogen infections, and provide auxiliary molecular diagnostic basis for the diagnosis and treatment of respiratory pathogen infections.

  • 14 Kinds of Genitourinary Tract Infection Pathogen

    14 Kinds of Genitourinary Tract Infection Pathogen

    The kit is intended for the in vitro qualitative detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus type 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus type 2 (HSV2), Ureaplasma parvum (UP), Mycoplasma genitalium (Mg), Candida albicans (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Group B streptococci (GBS), Haemophilus ducreyi (HD), and Treponema pallidum (TP) in male urethral swab, female cervical swab, and female vaginal swab samples, and provide aid to the diagnosis and treatment of patients with genitourinary tract infections.

  • SARS-CoV-2/influenza A /influenza B

    SARS-CoV-2/influenza A /influenza B

    This kit is suitable for in vitro qualitative detection of SARS-CoV-2, influenza A and influenza B nucleic acid of the nasopharyngeal swab and oropharyngeal swab samples which of the people who were suspected infection of SARS-CoV-2, influenza A and influenza B. It also can be used in suspected pneumonia and suspected cluster cases and for qualitative detection and identify of SARS-CoV-2, influenza A and influenza B nucleic acid in nasopharyngeal swab and oropharyngeal swab samples of novel Coronavirus infection in other circumstances.

123456 Next > >> Page 1 / 9